There is no so-called “optimal” solution for type 2 respiratory failure. Currently, the main treatment is to keep the airway open, oxygen therapy and other supportive treatments, and the key is to treat the cause.
Type 2 respiratory failure can be caused by chronic obstructive pulmonary disease, chronic pulmonary heart disease, pneumonia, bronchodilatation, etc., manifested by hypoxemia and hypercapnia.
The treatment of type 2 respiratory failure is based on respiratory support, which requires clearing airway secretions, establishing artificial airway to maintain airway patency, and low-flow oxygen (oxygen concentration <35%), positive pressure mechanical ventilation and extracorporeal membrane oxygenation if necessary.
Type 2 expiratory failure in maintaining respiratory stability, to resolve the harm caused by respiratory failure itself, need to address the cause of the treatment, such as lung infections leading to acute exacerbation of chronic expiratory failure can be taken more often than not, such as ceftazidime and other antibiotics anti-infection treatment.
In addition, some general supportive treatment can also be carried out, if there is acid-base balance disorder, can correct respiratory acidosis, potassium supplementation, etc.; if necessary, can also use doxapram and other respiratory stimulants.
It is recommended that people with type 2 respiratory failure should consult a doctor for timely examination and treatment, and medications should be used under the guidance of a physician.